Skip to Main Content

In the latest sign of anger over the cost of insulin, the Minnesota attorney general on Tuesday filed a lawsuit accusing the three largest manufacturers — Eli Lilly, Sanofi and Novo Nordisk — with deceptively raising prices, the first state to go to court over the issue.

“Insulin is a life-or-death drug for people with diabetes,” said Minnesota Attorney General Lori Swanson in a statement. “Many people can’t afford the price hikes but can’t afford to stop taking the medication either.” As an example, the lawsuit cited the Lantus insulin sold by Sanofi, which cost $99.35 for a 10-milliliter vial in 2010, now costs $269.54.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

  • When I was on Medicare and a supplement insurance, I was paying $1000 a month for my insulin. Now, working for HealthPartners, I have excellent insurance and only pay $10 for a month’s worth of insulin. At $1000, I told my endocrinologist that it was either the mortgage or the insulin….I could not afford both.

Comments are closed.